Clinical characteristics of patients with COVID-19 depending on the treatment received and the presence of type 2 diabetes mellitus
BACKGROUND. Type 2 diabetes mellitus (T2DM) is an independent risk factor for adverse clinical outcomes in patients with Covid-19. There is currently insufficient data evaluating the efficacy and safety of drugs for the treatment of COVID-19, especially in patients with T2DM.AIM. The aim of study wa...
Enregistré dans:
Auteurs principaux: | K. G. Lobanova, T. Y. Demidova, S. N. Perekhodov, M. B. Antsiferov |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/29d10e5a50dc4997bfee9c462bc4d108 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
par: Tatiana Ivanovna Romantsova, et autres
Publié: (2013) -
Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
par: Ivan Ivanovich Dedov, et autres
Publié: (2011) -
Initiation and intensification of antihyperglycemic therapy in type 2 diabetes mellitus: Update of Russian Association of Endocrinologists expert consensus document (2015)
par: Ivan Ivanovich Dedov, et autres
Publié: (2015) -
The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
par: Nina Viktorovna Bolotova, et autres
Publié: (2010) -
Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
par: I Yu Demidova, et autres
Publié: (2009)